Main content
CSL Bioplasma Feature
Through a number of undirected educational grants, CSL Bioplasma enables expert clinicians to design and implement educational programs that enhance health care by facilitating educational opportunities for clinicians practising in the Asia Pacific region.
Our educational grants have facilitated the creation of Asia Pacific expert groups in neurology and immunology and also their authoring of consensus recommendations on the use of intravenous immunoglobulins (IVIg) in these two complex areas of medicine.
Comprised of thought leaders from Australia, New Zealand, Taiwan, Hong Kong, Malaysia, Singapore, Thailand, the US and the UK, these expert groups produce consensus recommendations for dissemination at scientific congresses and symposia that they scope and implement. Held both in Asia and Australia, these events are associated with the programs of relevant medical societies and colleges.
The consensus recommendations provide an excellent resource for clinicians beginning their specialised training. In Asia, where care may be delivered by a general physician, the recommendations provide invaluable diagnostic and treatment information and assist optimal patient outcomes associated with the use of IVIg.
In immunology, our grants support the Asia Pacific Primary Immune Deficiency (APPID) Summer School for immunology registrars, and the APPID Interactive Update for consultant immunologists. Led by international scientific faculties, the APPID programs provide small group, highly advanced learning experiences. A similar program is planned in neurology.
We are also a long term supporter of the Australasian Society of Clinical Immunology and Allergy (ASCIA) annual scientific meetings, the Primary Immunodeficiency Disease (PID) register and the PID register scientific research awards.
In both neurology and immunology, we sponsor Fellowships at the Royal Children’s Hospital in Melbourne, providing a useful additional resource for the hospital. When the Fellow is a young clinician visiting from Asia, our sponsorship contributes towards enhanced health care in their home country.
In the intensive care unit of Sichuan Hua Xi Hospital, a nurse infuses CSL's human albumin into a patient injured in the recent earthquake. Following this earthquake tragedy in Sichuan Province, CSL quickly responded providing emergency supplies of albumin to numerous provincial hospitals in the region.